1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
  5. > Hyaluronic Acid Viscosupplementation Market Analysis: By Course of Treatment (Single Injection, Multiple Injections); By Osteoarthritis (Knee, Hip, Ankle, and Shoulder) - Forecast (2015 - 2020)

Viscosupplementation is the treatment for Osteoarthritis which is the most common joint disease affecting the middle age to elderly section of the people. In this method, doses of hyaluronic acid are given through injections in affected joints in the synovial fluid. The course of treatment can be of single injection formulation or subsequent doses of multiple-injection (three-injection) formulation. Viscosupplementation helps in reducing pain and improving joint movements.
Currently the market for Hyaluronic Acid Viscosupplementation is estimated to be around $2 billion and is poised to grow in the future. The steady growth of 6.5% can be attributed to the rise in the geriatric population globally as Osteoarthritis affects the aging population to a great extent. Also, the rise in cases of obesity worldwide has led to higher prevalence of Osteoarthritis leading to a growing demand for its treatment. These factors will provide a strong impetus to the growth of Hyaluronic Acid Viscosupplementation market. In India, Osteoarthritis is prevalent amongst 30-35% of its aging population which is a driving factor for the growth of Hyaluronic Acid Viscosupplementation market in the country (Satelli, 2014).
Injection site pain and joint pain swelling can be the restraining factors for the growth of the Hyaluronic Acid Viscosupplementation market. The global market for Hyaluronic Acid Viscosupplementation is expected to grow with the intensive research being conducted on the usage of Hyaluronic Acid and Viscosupplmentation for different types of joint treatment.

Table Of Contents

Hyaluronic Acid Viscosupplementation Market Analysis: By Course of Treatment (Single Injection, Multiple Injections); By Osteoarthritis (Knee, Hip, Ankle, and Shoulder) - Forecast (2015 - 2020)
1. Hyaluronic Acid Viscosupplementation Market Overview
2. Executive Summary
3. Hyaluronic Acid Viscosupplementation Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.2.1. Product Benchmarking
3.2.2. End user profiling
3.2.3. Patent Analysis
3.2.4. Top 5 Financials Analysis
4. Hyaluronic Acid Viscosupplementation Market Forces
4.1. Market Drivers
4.2. Market Constraints
4.3. Market Challenges
4.4. Attractiveness of the Industry
4.4.1. Power of Suppliers
4.4.2. Power of Customers
4.4.3. Threat of New entrants
4.4.4. Threat of Substitution
4.4.5. Degree of Competition
5. Hyaluronic Acid Viscosupplementation Market- Strategic Analysis
5.1. Value Chain Analysis
5.2. Opportunities Analysis
5.3. Product/Market Life Cycle Analysis
5.4. Pricing Analysis
6. Hyaluronic Acid Viscosupplementation Market- By Course of Treatment
6.1. By Single Injection
6.2. By Multiple Injections
7. Hyaluronic Acid Viscosupplementation Market- By Anatomy
7.1. Knee Osteoarthritis
7.2. Hip Osteoarthritis
7.3. Ankle Ostereoarthritis
7.4. Shoulder Osteoarthritis
8. Hyaluronic Acid Viscosupplementation Market- Geographic Analysis
8.1. Introduction
8.2. Americas
8.2.1. Canada
8.2.2. US
8.2.3. Brazil
8.2.4. Others
8.3. Europe
8.3.1. U.K.
8.3.2. Germany
8.3.3. France
8.3.4. Spain
8.3.5. Netherland
8.3.6. Others
8.4. APAC
8.4.1. China
8.4.2. Japan
8.4.3. India
8.4.4. South Korea
8.4.5. Australia
8.4.6. Others
8.5. ROW
9. Market Entropy
9.1. New Product Launches
9.2. MandAs, Collaborations, JVs and Partnerships
10. Company Profiles (Overview, Financials, Strategy, Developments, Product Portfolio)
10.1. Euflexxa
10.2. Fidia Farma USA Inc.
10.3. Anika Therapeutics, Inc.
10.4. Synvisc -One
10.5. Supartz
10.6. Zimmer, Inc.
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Frontier Pharma: Rheumatoid Arthritis - Cytokine Mediators and Kinase Inhibitors Dominate First-in-Class Product Innovation

Frontier Pharma: Rheumatoid Arthritis - Cytokine Mediators and Kinase Inhibitors Dominate First-in-Class Product Innovation

  • $ 6995
  • Industry report
  • August 2016
  • by GBI Research

Frontier Pharma: Rheumatoid Arthritis - Cytokine Mediators and Kinase Inhibitors Dominate First-in-Class Product Innovation Summary Rheumatoid Arthritis (RA) is a chronic, progressive and currently incurable ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...

Global Markets for Diabetes Therapeutics and Diagnostics

Global Markets for Diabetes Therapeutics and Diagnostics

  • $ 6650
  • Industry report
  • September 2016
  • by BCC Research

Use this report to: - Analyze the market for drugs used in the treatment of diabetes, it's technology and the industry as a whole - Identify important trends and provide sales forecasts by product categories ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.